Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies
Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease that primarily affects
the lining of the synovial joints and is associated with progressive disability, premature …
the lining of the synovial joints and is associated with progressive disability, premature …
Autoimmune pre-disease
Approximately 5% of the world-wide population is affected by autoimmune diseases.
Overall, autoimmune diseases are still difficult to treat, impose a high burden on patients …
Overall, autoimmune diseases are still difficult to treat, impose a high burden on patients …
2016 update of the EULAR recommendations for the management of early arthritis
Objectives Since the 2007 recommendations for the management of early arthritis have
been presented, considerable research has been published in the field of early arthritis …
been presented, considerable research has been published in the field of early arthritis …
Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis
M Haroon, P Gallagher, O FitzGerald - Annals of the rheumatic …, 2015 - ard.bmj.com
Objectives (1) To investigate the demographic and clinical characteristics contributing to the
delay from symptom onset to the first visit to a rheumatologist;(2) to compare clinical …
delay from symptom onset to the first visit to a rheumatologist;(2) to compare clinical …
EULAR definition of arthralgia suspicious for progression to rheumatoid arthritis
HW van Steenbergen, D Aletaha… - Annals of the …, 2017 - ard.bmj.com
Background During the transition to rheumatoid arthritis (RA) many patients pass through a
phase characterised by the presence of symptoms without clinically apparent synovitis …
phase characterised by the presence of symptoms without clinically apparent synovitis …
Respiratory viral infections and the risk of rheumatoid arthritis
Background We aimed to investigate the effects of ambient respiratory viral infections in the
general population on rheumatoid arthritis (RA) development. Methods Data of weekly …
general population on rheumatoid arthritis (RA) development. Methods Data of weekly …
Rheumatoid arthritis prevention in arthralgia: fantasy or reality?
HW van Steenbergen, AP Cope… - Nature Reviews …, 2023 - nature.com
The concept of a 'window of opportunity'in treating a disease assumes the existence of a
time frame during which the trajectory of the disease can be effectively and permanently …
time frame during which the trajectory of the disease can be effectively and permanently …
What is the evidence for the presence of a therapeutic window of opportunity in rheumatoid arthritis? A systematic literature review
JAB Van Nies, A Krabben, JW Schoones… - Annals of the …, 2014 - ard.bmj.com
Objective Initiation of DMARD-therapy in the 'window of opportunity'is thought to result in a
more effective modification of the processes underlying rheumatoid arthritis (RA). We …
more effective modification of the processes underlying rheumatoid arthritis (RA). We …
Window of opportunity in rheumatoid arthritis–definitions and supporting evidence: from old to new perspectives
LE Burgers, K Raza, AH Van Der Helm-Van - RMD open, 2019 - rmdopen.bmj.com
The therapeutic window of opportunity in rheumatoid arthritis (RA) is often referred to.
However, some have questioned whether such a period, in which the disease is more …
However, some have questioned whether such a period, in which the disease is more …
Predicting the development of clinical arthritis in anti-CCP positive individuals with non-specific musculoskeletal symptoms: a prospective observational cohort study
C Rakieh, JL Nam, L Hunt, EMA Hensor… - Annals of the …, 2015 - ard.bmj.com
Objectives To monitor progression to inflammatory arthritis (IA) in individuals with non-
specific musculoskeletal (MSK) symptoms and positive anticyclic citrullinated peptide (anti …
specific musculoskeletal (MSK) symptoms and positive anticyclic citrullinated peptide (anti …